TOP TIERMARKET NEWSWIRE
News & sentiment

TSCAN THERAPEUTICS I (TCRX) — News & AI sentiment

TSCAN THERAPEUTICS I (TCRX) news roundup. 14 stories aggregated over the last 30 days. Average 30-day sentiment is 44.1/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
14
avg sentiment 44.1/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

TCRX news in the last 24 hours, 7 days, 30 days and 90 days

How much TCRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTCRX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1444.1/100TCRX headlines →
Last 90 days2147.1/100TCRX headlines →

Latest stories on TCRX

Sep 11
Sep 11
Sep 8
Sep 4
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Why is TScan Therapeutics stock collapsing today?
Investing.com Markets32 · bearishgeneral
Sep 2
Sep 2
Sep 2
Sep 2
Sep 2
Aug 18
H.C. Wainwright reiterates Tscan Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 13
Aug 12
Aug 12
Aug 12
Aug 12
Jul 29
Jun 24
Jun 22
Jun 22
Jun 22
Open TCRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →